Contents Vol. 69, 2016Ying-xiu Zhang, Hamid Abdi, Mohammad Sadegh Rahmanian et al.|Annals of Nutrition and Metabolism|2016Cited by 0
Acknowledgement to the ReviewersYing-xiu Zhang, Hamid Abdi, Mohammad Sadegh Rahmanian et al.|Annals of Nutrition and Metabolism|2016Cited by 0
FENS NewsYing-xiu Zhang, Hamid Abdi, Mohammad Sadegh Rahmanian et al.|Annals of Nutrition and Metabolism|2016Cited by 0
AB0609 DESIGN OF A PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED, GLOBAL TRIAL OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 (TYK2) INHIBITOR, IN PATIENTS WITH ACTIVE DISCOID AND/OR SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUSVictoria P. Werth, Shimon Korish, Joseph F. Merola et al.|Unknown|2023Cited by 0